
The shift exposes a manufacturing constraint the Army is only now articulating publicly. Patriot production had consolidated around PAC-3 MSE because it was the 'easy button' — one missile, one supply chain, predictable sustainment.
Restarting GEM-T production and launching four new programs simultaneously means the Army is willing to accept higher unit costs and logistics complexity to avoid the 2022-2026 lesson: when Iran choked the Hormuz and forced Project Freedom into active combat, air defense munitions consumption outpaced production, and the service had no alternative round to cycle in. Every new system now must be multi-round capable, which adds weight and reduces magazine depth per platform — a tradeoff the Iran campaign made unavoidable.
The Iran war exposed a single point of failure: when one interceptor type becomes the sole supply source, attrition and production constraints become existential.
The Army is now building redundancy into every layer — PAC-3 MSE production targets 2,000 per year, but the service just restarted PAC-2 GEM-T procurement (ended in 2023) and is running LCI, NGSRI, NGCM, and Second Interceptor programs in parallel. This forces every air defense platform redesign to accommodate multiple round types, which delays fielding but hardens the force against supply shock. Watch the FY27 AUSA markup in November — the Hill will demand unit costs for each program and a timeline to achieve 2,000 PAC-3 MSE annual production.
Which of the five interceptor programs is slated for production first, and at what annual volume? The article names the programs but not the procurement sequence or quantity targets.
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.